SAFETY OF INTRAVITREAL DEXAMETHASONE IMPLANT (OZURDEX) The SAFODEX study. Incidence and Risk Factors of Ocular Hypertension

Malcles Ariane; Dot Corinne; Voirin Nicolas; Vie Anne-Laure; Agard Emilie; Bellocq David; Denis Philippe; Kodjikian Laurent

首页> 外文期刊>Retina >SAFETY OF INTRAVITREAL DEXAMETHASONE IMPLANT (OZURDEX) The SAFODEX study. Incidence and Risk Factors of Ocular Hypertension

【24h】

SAFETY OF INTRAVITREAL DEXAMETHASONE IMPLANT (OZURDEX) The SAFODEX study. Incidence and Risk Factors of Ocular Hypertension

机译：玻璃体内地塞米松的安全性植入物（Ozurdex）Safodex研究。眼高血压的发病率和危险因素

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Purpose: To analyze the incidence, risk factors, and time course of intraocular pressure elevation after intravitreal dexamethasone implant (Ozurdex).

机译：目的：分析玻璃天递植入物植入物（Ozurdex）后眼压升高的发生率，危险因素和时间过程。

著录项

来源
《Retina》 |2017年第7期|共8页
作者
Malcles Ariane; Dot Corinne; Voirin Nicolas; Vie Anne-Laure; Agard Emilie; Bellocq David; Denis Philippe; Kodjikian Laurent;
展开▼
作者单位

Univ Med Lyon 1 Croix Rousse Univ Hosp Dept Ophthalmol Hosp Civils Lyon CNRS UMR Mateis 5510;

Desgenettes Mil Hosp Dept Ophthalmol Lyon France;

Univ Med Lyon 1 Croix Rousse Univ Hosp Dept Ophthalmol Hosp Civils Lyon CNRS UMR Mateis 5510;

Univ Med Lyon 1 Croix Rousse Univ Hosp Dept Ophthalmol Hosp Civils Lyon CNRS UMR Mateis 5510;

Desgenettes Mil Hosp Dept Ophthalmol Lyon France;

Univ Med Lyon 1 Croix Rousse Univ Hosp Dept Ophthalmol Hosp Civils Lyon CNRS UMR Mateis 5510;

Univ Med Lyon 1 Croix Rousse Univ Hosp Dept Ophthalmol Hosp Civils Lyon CNRS UMR Mateis 5510;

Univ Med Lyon 1 Croix Rousse Univ Hosp Dept Ophthalmol Hosp Civils Lyon CNRS UMR Mateis 5510;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类眼科学;
关键词
adverse effects; corticosteroid; dexamethasone implant; intraocular pressure; ocular hypertension; ozurdex; risk factors;

机译：不良反应;皮质类固醇;地塞米松植入物;眼压;眼高血压;Ozurdex;风险因素;

相似文献

外文文献
中文文献
专利

1. SAFETY OF INTRAVITREAL DEXAMETHASONE IMPLANT (OZURDEX) The SAFODEX study. Incidence and Risk Factors of Ocular Hypertension [J] . Malcles Ariane, Dot Corinne, Voirin Nicolas, Retina . 2017,第7期

机译：玻璃体内地塞米松的安全性植入物（Ozurdex）Safodex研究。眼高血压的发病率和危险因素
2. OCULAR HYPERTENSION AFTER INTRAVITREAL DEXAMETHASONE (OZURDEX) SUSTAINED-RELEASE IMPLANT [J] . Chin Eric K., Almeida David R. P., Velez Gabriel, Retina . 2017,第7期

机译：玻璃体内甲基塞内酮（Ozurdex）持续释放植入物后眼睑高血压
3. Secondary ocular hypertension after dexamethasone intravitreal implant (Ozurdex) in the routine clinical practice [J] . Kornwipa Hemarat, Jacquelyn D. Kemmer, Alexander M. Eaton, Investigative ophthalmology & visual science . 2016,第12期

机译：常规临床实践中地塞米松玻璃体植入物（Ozurdex）后继发性高眼压
4. Correlation Between Genetic factors and the Incidence of ocular Hypertension Glaucoma/Normal tension Glaucoma [C] . Yali Feng, Wenshuang Xu, Zhe Cui International Conference on Electronics, Mechanics, Culture and Medicine . 2015

机译：遗传因子与眼高血压青光眼/正常张力葡萄糖发生率的相关性
5. Incidence and clinical predictors of risk factors for inappropriate shock in patients with implantable cardioverter-defibrillators [D] . Lo, Shu-Ling 2005

机译：植入式心脏复律除颤器患者不适当电击危险因素的发生率和临床预测因素
6. Ocular Hypertension after Intravitreal Dexamethasone (Ozurdex) Sustained-Release Implant [O] . Eric K. Chin, David R.P. Almeida, Gabriel Velez, -1

机译：玻璃体内地塞米松（Ozurdex）缓释植入物后的眼压升高
7. OCULAR HYPERTENSION AFTER INTRAVITREAL DEXAMETHASONE (OZURDEX) SUSTAINED-RELEASE IMPLANT [O] . Eric K. Chin, David R. P. Almeida, Gabriel Velez, 2017

机译：玻璃体内甲基塞洛塞（Ozurdex）持续释放植入物后的眼高血压

SAFETY OF INTRAVITREAL DEXAMETHASONE IMPLANT (OZURDEX) The SAFODEX study. Incidence and Risk Factors of Ocular Hypertension

摘要

著录项

相似文献

相关主题

期刊订阅